PLSE - Pulse Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
49,494
47,954
37,963
25,814
9,586
Operating Income
-49,494
-47,954
-37,963
-25,814
-9,586
Net Non Operating Interest Income Expense
729
983
446
247
68
Other Income Expense
-
-
-28
-
-
Pretax Income
-48,765
-46,971
-37,545
-25,567
-9,518
Tax Provision
-
0
0
0
0
Net Income Common Stockholders
-48,765
-46,971
-37,545
-25,567
-9,518
Diluted NI Available to Com Stockholders
-48,765
-46,971
-37,545
-25,567
-9,518
Basic EPS
-
-0.0023
-0.0022
-0.0017
0
Diluted EPS
-
-0.0023
-0.0022
-0.0017
0
Basic Average Shares
-
20,746
17,078
14,754
11,009
Diluted Average Shares
-
20,746
17,078
14,754
11,009
Total Expenses
49,494
47,954
37,963
25,814
9,586
Net Income from Continuing & Discontinued Operation
-48,765
-46,971
-37,545
-25,567
-9,518
Normalized Income
-48,765
-46,971
-37,545
-25,567
-9,518
Interest Income
729
983
446
247
68
Net Interest Income
729
983
446
247
68
EBIT
-49,494
-47,954
-37,963
-25,814
-9,586
EBITDA
-48,393
-
-
-
-
Reconciled Depreciation
1,101
1,160
1,310
1,001
759
Net Income from Continuing Operation Net Minority Interest
-48,765
-46,971
-37,545
-25,567
-9,518
Normalized EBITDA
-48,393
-46,794
-36,653
-24,813
-8,827
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0